B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-10

Study Completion Date

2035-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectif is to study the diagnosis performance of the different classification criteria in reference to the gold standard consisting of the diagnosis made by expert doctors after standardized assessment, of pSS (primary Sjogren syndrome)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

NCT03003572

Primary Sjögren's Syndrome

RECRUITING

The ASSESS National Multi-center Prospective Cohort

NCT03040583

Primary Sjögren's Syndrome

RECRUITING

Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)

NCT06680310

Sjogren Syndrome Dry Syndrome Lupus +2 more

NOT_YET_RECRUITING

SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases

NCT05022420

Tolerance Biopsy Site Itching

RECRUITING

Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome

NCT05312944

Polymyalgia Rheumatica Sjogren's Syndrome

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The formation of this patient is single-center prospective intervention. It consists of collecting data from patients suspected of pSS from standardized biological clinical data and imaging examination and additional pathology.

* Sjögren patients will be followed at inclusion, 2y, 3y, 4y, 6y, 8y and 10 years. Blood, fluid, sells and urine samples will be collected at inclusion, 4y et 10y.
* Non-Sjögren controls will be followed at inclusion and 4y and samples will be collected at the same visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sjogren's Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

* Sjögren patients
* Non-Sjögren controls (retrospective)

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sjögren patients

patients diagnosed Sjögren

Group Type ACTIVE_COMPARATOR

Blood, fluid, sells and urine samples

Intervention Type OTHER

Blood, fluid, sells and urine samples will be collected.

Non-Sjögren witnesses

patients diagnosed no Sjögren

Group Type OTHER

Blood, fluid, sells and urine samples

Intervention Type OTHER

Blood, fluid, sells and urine samples will be collected.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood, fluid, sells and urine samples

Blood, fluid, sells and urine samples will be collected.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major patient
* Suspicion of SSp (clinical or biological criteria, i.e. dry eye or oral syndrome, arthritis, parotidomegaly, neuropathy, kidney or lung disease...)
* Patient affiliated with Social Security
* Patient who has signed written informed consent